Seeking Alpha

SeraCare Life Sciences (SRLS) says it will explore and evaluate potential strategic alternatives...

SeraCare Life Sciences (SRLS) says it will explore and evaluate potential strategic alternatives to enhance shareholder value, including a sale or other transaction, but there is no set timetable for making a decision. SRLS +3.3% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)